Randomized Clinical Trial
Copyright ©The Author(s) 2016.
World J Gastrointest Pharmacol Ther. Nov 6, 2016; 7(4): 572-578
Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.572
Figure 1
Figure 1 Endoscopic scoring system. Score of 1: No bubbles; Score of 2: Minimal bubbles which the endoscopist must actively look for; Score of 3: Foam is obviously present but not severe; Score of 4: Severe foam obscuring vision; Area A: Esophagus; Area B: The antrum and angularis of the stomach; Area C: The body and fundus of the stomach; Area D: Duodenum. TMVS is the sum of the scores of areas A, B, C and D added together. TMVS: Total mucosal visibility score.
Figure 2
Figure 2 Workflow of patient enrollment.
Figure 3
Figure 3 Endoscopist contribution per group.
Figure 4
Figure 4 Percentage of patients with total mucosal visibility score of 4-5 during gastroscopy. TMVS: Total mucosal visibility score.
Figure 5
Figure 5 Endoscopic images of a patient in the placebo group (total mucosal visibility score 13).
Figure 6
Figure 6 Endoscopic images of a patient in the simethicone group (total mucosal visibility score 4).
Figure 7
Figure 7 Correlation between volume of additional water flushes during gastroscopy (mL) and total mucosal inspection time (s).